Strategic Insight At the 44th Annual J.P. Morgan Healthcare Conference, Merck & Co. CEO Rob Davis unveiled an ambitious plan... Read more
Category: Uncategorized
Bayer announces new growth roadmap driven by rejuvenated portfolio
Corporate Focus On the second day of the 2026 J.P. Morgan Healthcare Conference, Stefan Oelrich, President of Bayer’s Pharmaceuticals Division,... Read more
AbbVie pledges $100B US investment in exchange for tariff exemptions
Healthcare Economics Update Pharmaceutical giant AbbVie has finalized a landmark accord with the White House,signaling a major shift in efforts... Read more
FDA approves first-ever treatment for Menkes disease
International Medical News The U.S. Food and Drug Administration (FDA) has officially granted approval to Zycubo (copper histidinate), making it... Read more
Ionis doubles sales forecast for blood lipid therapy
Corporate Update At the 2026 J.P. Morgan Healthcare Conference, Ionis Pharmaceuticals announced significant adjustments to its commercial expectations for its... Read more
New pharmaceutical strategies at the JPM 2026 conference
Market Summary The second day of the annual healthcare event in San Francisco witnessed a significant shift in how major... Read more
Hanoi: Large-scale medical drill deployed for national event
On January 12, 2026, the Ministry of Health spearheaded a field drill to prepare healthcare and emergency response plans for... Read more
Vietnam accelerates the roadmap for pharmaceutical autonomy and modernization
In a major move to boost national healthcare capacity, the Ministry of Health has recently reviewed the pharmaceutical sector's development... Read more
Hanoi strategizes to become a high-quality medical hub
In an effort to materialize long-term development orientations, Hanoi's healthcare sector is mobilizing all resources to build a sustainable health... Read more









